Botty Investors Llc decreased its stake in Boston Scientific Co (BSX) by 89.31% based on its latest 2019Q1 regulatory filing with the SEC. Botty Investors Llc sold 83,538 shares as the company’s stock declined 6.39% while stock markets rallied. The institutional investor held 10,000 shares of the medical and dental instruments company at the end of 2019Q1, valued at $384,000, down from 93,538 at the end of the previous reported quarter. Botty Investors Llc who had been investing in Boston Scientific Co for a number of months, seems to be less bullish one the $56.74B market cap company. The stock decreased 0.90% or $0.37 during the last trading session, reaching $40.8. About 6.92M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 24.15% since June 13, 2018 and is uptrending. It has outperformed by 19.72% the S&P500. Some Historical BSX News: 25/04/2018 – Boston Scientific Sees 2Q EPS 21c-EPS 23c; 25/04/2018 – Boston Scientific Profit Rises 2.8%; 21/03/2018 – Boston Scientific Expects NxThera Acquisition to Add to Adjusted EPS After 202; 16/04/2018 – Boston Scientific: Deal May Lead to New Diagnostic Options for Ovarian Cancer; 23/03/2018 – Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid; 28/03/2018 – Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation; 25/04/2018 – BOSTON SCIENTIFIC 1Q ADJ EPS 33C, EST. 32C; 07/05/2018 – Boston Scientific To Participate In Bank of America Merrill Lynch 2018 Health Care Conference; 16/04/2018 – BOSTON SCIENTIFIC CORP – ACQUISITION IS EXPECTED TO BE DILUTIVE ON A GAAP BASIS THROUGH 2020 AND LESS ACCRETIVE THEREAFTER DUE TO COSTS; 29/03/2018 – Boston Scientific Closes Above 50-Day Moving Average
Laffer Investments decreased its stake in Kohl’s Corp (KSS) by 0.4% based on its latest 2019Q1 regulatory filing with the SEC. Laffer Investments sold 198 shares as the company’s stock declined 3.44% while stock markets rallied. The institutional investor held 49,178 shares of the department and specialty retail stores company at the end of 2019Q1, valued at $3.38 billion, down from 49,376 at the end of the previous reported quarter. Laffer Investments who had been investing in Kohl’s Corp for a number of months, seems to be less bullish one the $7.77 billion market cap company. The stock increased 0.04% or $0.02 during the last trading session, reaching $47.97. About 3.69 million shares traded. Kohl's Corporation (NYSE:KSS) has risen 4.97% since June 13, 2018 and is uptrending. It has outperformed by 0.54% the S&P500. Some Historical KSS News: 22/05/2018 – KOHLS CORP QTRLY SHR $0.45; 26/04/2018 – Julius Baer’s David Kohl Says Europe Is Becoming ‘More and More Healthy’ (Video); 09/05/2018 – Amazon to let customers install tires at Sears stores; 02/04/2018 – Kohl’s Closes Below 50-Day Moving Average: Technicals; 10/04/2018 – Kohl’s: Richard D. Schepp, Chief Administrative Officer, to Retire in October; 02/04/2018 – KOHL’S REPORTS $300M CASH TENDER OFFER FOR SOME NOTES & DEBS; 16/04/2018 – KOHLS – INCREASED COMBINED PRINCIPAL AMOUNT OF NOTES & DEBENTURES CO MAY BUY IN PREVIOUSLY ANNOUNCED CASH TENDER OFFER FROM $300 MLN TO ABOUT $500 MLN; 21/05/2018 – Kohl’s Expands Millennial Brand Portfolio through an Apparel Collection with POPSUGAR; 22/05/2018 – Kohl’s 1Q Rev $4.21B; 10/05/2018 – Moody’s Affirms Eight Classes of COMM 2006-C8
Since January 3, 2019, it had 0 buys, and 7 insider sales for $3.25 million activity. Pierce David A also sold $175,000 worth of Boston Scientific Corporation (NYSE:BSX) shares. On Wednesday, January 9 Ralls-Morrison Desiree sold $145,692 worth of Boston Scientific Corporation (NYSE:BSX) or 4,047 shares. $107,727 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Nanavaty Maulik. 14,740 shares valued at $495,954 were sold by Ballinger Kevin J. on Thursday, January 3.
Investors sentiment increased to 1.38 in 2019 Q1. Its up 0.24, from 1.14 in 2018Q4. It is positive, as 36 investors sold BSX shares while 185 reduced holdings. 92 funds opened positions while 213 raised stakes. 1.21 billion shares or 1.61% less from 1.23 billion shares in 2018Q4 were reported. Diamond Hill Cap Mngmt holds 1.94 million shares or 0.41% of its portfolio. Sands Cap Mngmt Lc reported 160,193 shares. 3,950 are held by Focused Wealth Mgmt Inc. Moreover, C Worldwide Group Hldgs A S has 0.18% invested in Boston Scientific Corporation (NYSE:BSX) for 367,194 shares. Virginia Retirement Systems Et Al reported 465,700 shares. Agf Investments Incorporated reported 0.01% stake. 2,000 were reported by American Research & Mgmt Com. Checchi Cap Advisers Limited Company owns 11,148 shares for 0.05% of their portfolio. Jefferies Gp Ltd Com holds 0.03% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 93,350 shares. Howe Rusling owns 35 shares for 0% of their portfolio. Ptnrs Limited Liability Co holds 1.71% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 787,300 shares. Proffitt And Goodson has 61 shares for 0% of their portfolio. Twin Tree Mngmt Limited Partnership reported 0% in Boston Scientific Corporation (NYSE:BSX). 124,198 are held by Cibc Asset Mgmt. Bb&T Securities Ltd Com stated it has 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX).
More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Seekingalpha.com which released: “Boston Scientific buys remaining Millipede shares – Seeking Alpha” on December 27, 2018, also Investorplace.com with their article: “4 Drug and Health Stocks Pushing Higher – Investorplace.com” published on May 28, 2019, Finance.Yahoo.com published: “At US$37.20, Is It Time To Put Boston Scientific Corporation (NYSE:BSX) On Your Watch List? – Yahoo Finance” on May 06, 2019. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Investorplace.com and their article: “7 Safe Stocks to Buy for Anxious Investors – Investorplace.com” published on May 21, 2019 as well as Forbes.com‘s news article titled: “How Much Can Boston Scientific’s Cardiac Rhythm Management Business Grow In The Near Term? – Forbes” with publication date: June 12, 2019.
Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on July, 24. They expect $0.38 earnings per share, down 7.32% or $0.03 from last year’s $0.41 per share. BSX’s profit will be $528.45 million for 26.84 P/E if the $0.38 EPS becomes a reality. After $0.35 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 8.57% EPS growth.
More notable recent Kohl's Corporation (NYSE:KSS) news were published by: Schaeffersresearch.com which released: “Retailers Report Weak Same-Store Sales – Schaeffers Research” on May 21, 2019, also Nasdaq.com with their article: “5 Stocks Under $10 With Big Upside Potential – Nasdaq” published on May 30, 2019, Businesswire.com published: “Jason Wu to Design Exclusive Holiday Capsule for Kohl’s – Business Wire” on May 21, 2019. More interesting news about Kohl's Corporation (NYSE:KSS) were released by: Finance.Yahoo.com and their article: “Duquesne Family Officeâ€™s Latest Moves – Yahoo Finance” published on May 29, 2019 as well as Finance.Yahoo.com‘s news article titled: “Stocks – S&P Closes Higher as U.S. Temporarily Eases Huawei Restrictions – Yahoo Finance” with publication date: May 21, 2019.
Laffer Investments, which manages about $614.32 million and $372.00 billion US Long portfolio, upped its stake in At&T Inc (NYSE:T) by 1,332 shares to 63,747 shares, valued at $2.00B in 2019Q1, according to the filing. It also increased its holding in Lyondellbasell Industries Nv (NYSE:LYB) by 391 shares in the quarter, for a total of 6,887 shares, and has risen its stake in Deutsche Bank Ag London/Voya.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.